Physician profile
Leonor Forero
NPI 1043202161
$2,961.87
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,224 · 2020: $119 · 2021: $311 · 2022: $330 · 2023: $702 · 2024: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $390.35 | 2019-2024 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $335.04 | 2019-2024 | Airsupra |
| Pfizer INC. | $323.98 | 2019-2023 | |
| Glaxosmithkline, LLC. | $262.62 | 2019-2023 | Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $220.09 | 2021-2023 | Rexulti |
| Merck Sharp & Dohme LLC | $209.72 | 2019-2023 | Gardasil 9, Rotateq, Vaxneuvance |
| Lilly USA, LLC | $205.91 | 2019-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.78 | 2019-2023 | Tradjenta, Jardiance |
| Abbvie INC. | $138.95 | 2021-2022 | |
| Novo Nordisk INC | $120.40 | 2019-2023 | |
| Esperion Therapeutics, INC. | $77.80 | 2021-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $72.03 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $66.19 | 2019-2022 | |
| Amarin Pharma, INC. | $59.84 | 2019-2020 | |
| Abbott Laboratories | $57.24 | 2022-2023 | Freestyle Libre 2 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $47.47 | 2019 | |
| Alkermes, INC. | $37.46 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.99 | 2019 | |
| Phathom Pharmaceuticals, INC. | $25.49 | 2024 | Voquezna |
| Nevro Corp. | $19.67 | 2021 | |
| Allergan, INC. | $18.06 | 2020 | |
| Scynexis, INC. | $17.42 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.64 | 2019 | |
| Exact Sciences Corporation | $14.28 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $13.15 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonor Forero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.